Switch to:
More From Other Websites
Halozyme To Host Fourth Quarter And 2015 Year-End Financial Results Conference Call Feb 01 2016
Halozyme To Host Fourth Quarter And 2015 Year-End Financial Results Conference Call Feb 01 2016
Halozyme Announces Closing Of $150 Million Royalty-Backed Debt Financing Jan 26 2016
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 26 2016
Halozyme Announces Closing Of $150 Million Royalty-Backed Debt Financing Jan 26 2016
Halozyme Gets $5M as AbbVie Begins Dosing in Humira Trial Jan 22 2016
Halozyme Confirms $5 Million Milestone Payment From AbbVie Jan 21 2016
5 Stocks Under $10 Set to Soar Jan 21 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE™ Technology Jan 21 2016
Halozyme Therapeutics (HALO) in Focus: Stock Rises 6.7% Jan 21 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE™ Technology Jan 21 2016
4 Top BioPharma Movers of the Past Week Jan 16 2016
Small Companies, Big Declines: Why These Stocks Tumbled Today Jan 13 2016
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 13 2016
Halozyme Therapeutics (HALO) in Focus: Stock Tumbles 16.7% Jan 12 2016
The News that Prompted Furious Trading in These 4 Stocks Today Jan 11 2016
Halozyme Therapeutics Sinks on Business Update Jan 11 2016
Halozyme Provides Key Program Updates, 2016 Financial Guidance At 34th Annual JP Morgan Healthcare... Jan 11 2016
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK